1 active not recruiting, 1 completed, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Bone Neoplasm: new trials by email Literature Review of Bone Neoplasm trials Research Report on Bone Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis combined radiotherapy and MR-HIFU - Bone Metastases, Bone Neoplasm | Phase 1 / Phase 2 | Completed | UMC Utrecht | 10 | 2019-04-11 | 2024-02-07 |
| 9-ING-41 in Patients With Advanced Cancers 9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin. - Cancer, Pancreatic Cancer | Phase 2 | Active not recruiting | Actuate Therapeutics Inc. | 350 | 2019-01-04 | 2026-04-03 |
| A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. ibandronate [Bondronat] - Pain, Bone Neoplasm | Phase 2 | Withdrawn | Hoffmann-La Roche | 2007-06-01 | 2017-08-16 |
Bone Neoplasms (3) · Neoplasm Metastasis (3) · Neoplasms (2) · Pain (2) · Breast Neoplasms (1) · Colorectal Neoplasms (1) · Glioma (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Kidney Neoplasms (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lung Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Pancreatic Neoplasms (1) · Radiation Injuries (1) · Sarcoma (1)
Bone Diseases (3) · Musculoskeletal Diseases (3) · Neoplasms by Site (3) · Neoplastic Processes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Breast Diseases (1) · Colonic Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1)
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1) · Albumin-Bound Paclitaxel (1) · Carboplatin (1) · Doxorubicin (1) · Gemcitabine (1) · Ibandronic Acid (1) · Irinotecan (1) · Lomustine (1) · Paclitaxel (1) · Taxes (1) · liposomal doxorubicin (1)
Actuate Therapeutics Inc. (1) · Hoffmann-La Roche (1) · UMC Utrecht (1)
Netherlands (2) · Belgium (1) · Canada (1) · France (1) · Greece (1) · Portugal (1) · Spain (1) · United States (1)
Helena M Verkooijen, MD, PhD (1)
PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 30405781, PMID 30975030, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 35815408, PMID 41981308